Novel ARX mutation identified in infantile spasm syndrome patient

Area of Science:

• Genetics
• Neurology
• Pediatrics

Background:

• Infantile spasms are a severe form of epilepsy in infants.
• The Aristaless-related homeobox (ARX) gene is known to be associated with various neurodevelopmental disorders, including epilepsy.
• Identifying novel mutations is crucial for understanding disease mechanisms and developing targeted therapies.

Purpose of the Study:

• To report a novel mutation in the ARX gene associated with infantile spasms.
• To describe the clinical presentation and treatment challenges in a patient with this mutation.

Main Methods:

• Clinical case presentation of a 7-year-old boy with infantile spasms.
• Electroencephalogram (EEG) and brain Magnetic Resonance Imaging (MRI) for diagnosis.
• Exome sequencing to identify the genetic cause.
• Review of treatment responses to adrenocorticotropic hormone (ACTH), ketogenic diet, and anti-epileptic drugs.

Main Results:

• The patient presented with infantile spasms and hypsarrhythmia from early infancy.
• Standard treatments including adrenocorticotropic hormone (ACTH) therapy were ineffective.
• Exome sequencing revealed a novel hemizygous mutation in the ARX gene (NG_008281.1(ARX_v001):c.1448+1G>A).
• The patient required ketogenic diet and multiple anti-epileptic drugs for intractable seizures.

Conclusions:

• A novel mutation in the ARX gene can cause infantile spasms and intractable epilepsy.
• This finding expands the spectrum of ARX-related disorders.
• Further research into ARX gene function is warranted for understanding and treating related epilepsies.